Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial.

Moulin DE, Morley-Forster PK, Pirani Z, Rohfritsch C, Stitt L.

Can J Anaesth. 2019 Jul;66(7):820-827. doi: 10.1007/s12630-019-01395-8. Epub 2019 May 16.

PMID:
31098961
2.

The impact of integrated disease management in high-risk COPD patients in primary care.

Ferrone M, Masciantonio MG, Malus N, Stitt L, O'Callahan T, Roberts Z, Johnson L, Samson J, Durocher L, Ferrari M, Reilly M, Griffiths K, Licskai CJ; Primary Care Innovation Collaborative.

NPJ Prim Care Respir Med. 2019 Mar 28;29(1):8. doi: 10.1038/s41533-019-0119-9.

3.

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.

Singh S, Stitt LW, Zou G, Khanna R, Dulai PS, Sandborn WJ, Feagan BG, Jairath V.

Aliment Pharmacol Ther. 2019 May;49(9):1188-1194. doi: 10.1111/apt.15214. Epub 2019 Mar 19.

PMID:
30891808
4.

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.

Jairath V, Peyrin-Biroulet L, Zou G, Mosli M, Vande Casteele N, Pai RK, Valasek MA, Marchal-Bressenot A, Stitt LW, Shackelton LM, Khanna R, D'Haens GR, Sandborn WJ, Olson A, Feagan BG, Pai RK.

Gut. 2019 Jul;68(7):1162-1168. doi: 10.1136/gutjnl-2018-316702. Epub 2018 Aug 3.

PMID:
30076171
5.

Long-Term Outcomes in the Management of Central Neuropathic Pain Syndromes: A Prospective Observational Cohort Study.

Staudt MD, Clark AJ, Gordon AS, Lynch ME, Morley-Forster PK, Nathan H, Smyth C, Stitt LW, Toth C, Ware MA, Moulin DE.

Can J Neurol Sci. 2018 Sep;45(5):545-552. doi: 10.1017/cjn.2018.55. Epub 2018 Jul 12.

PMID:
29996953
6.

Evaluation of the effect of storage condition on cell extraction and flow cytometric analysis from intestinal biopsies.

Wildenberg ME, Duijvestein M, Westera L, van Viegen T, Buskens CJ, van der Bilt JDW, Stitt L, Jairath V, Feagan BG, Vande Casteele N.

J Immunol Methods. 2018 Aug;459:50-54. doi: 10.1016/j.jim.2018.05.004. Epub 2018 Jun 1.

PMID:
29772249
7.

Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabine.

Breadner D, Vincent MD, Jonker D, Cripps C, Klimo P, Biagi J, Lam W, O'Connell A, Whiston F, Stitt L, Welch S.

J Geriatr Oncol. 2018 Nov;9(6):659-664. doi: 10.1016/j.jgo.2018.04.002. Epub 2018 May 2.

PMID:
29728308
8.

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis.

Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, Nelson S, Stitt L, Bloom S, Pardi DS, Gionchetti P, Lindsay J, Travis S, Hart A, Silverberg MS, Feagan BG, D'Haens GR, Jairath V.

Gastrointest Endosc. 2018 Aug;88(2):360-369.e2. doi: 10.1016/j.gie.2018.04.2330. Epub 2018 Apr 13.

PMID:
29660321
9.

Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease.

Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, van 't Wout AB, Atreya R, Vieth M, Brandse JF, Duijst S, Te Velde AA, D'Haens GRAM, Levesque BG, van den Brink GR.

J Crohns Colitis. 2018 Jun 28;12(7):794-803. doi: 10.1093/ecco-jcc/jjy035.

10.

Reliability of histologic assessment in patients with eosinophilic oesophagitis.

Warners MJ, Ambarus CA, Bredenoord AJ, Verheij J, Lauwers GY, Walsh JC, Katzka DA, Nelson S, van Viegen T, Furuta GT, Gupta SK, Stitt L, Zou G, Parker CE, Shackelton LM, D Haens GR, Sandborn WJ, Dellon ES, Feagan BG, Collins MH, Jairath V, Pai RK.

Aliment Pharmacol Ther. 2018 Apr;47(7):940-950. doi: 10.1111/apt.14559. Epub 2018 Feb 20.

PMID:
29460418
11.

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography.

Jairath V, Ordas I, Zou G, Panes J, Stoker J, Taylor SA, Santillan C, Horsthuis K, Samaan MA, Shackelton LM, Stitt LW, Hindryckx P, Khanna R, Sandborn WJ, D'Haens G, Feagan BG, Levesque BG, Rimola J.

Inflamm Bowel Dis. 2018 Jan 18;24(2):440-449. doi: 10.1093/ibd/izx040.

PMID:
29361096
12.

Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study.

Westera L, van Viegen T, Jeyarajah J, Azad A, Bilsborough J, van den Brink GR, Cremer J, Danese S, D'Haens G, Eckmann L, Faubion W, Filice M, Korf H, McGovern D, Panes J, Salas A, Sandborn WJ, Silverberg MS, Smith MI, Vermeire S, Vetrano S, Shackelton LM, Stitt L, Jairath V, Levesque BG, Spencer DM, Feagan BG, Vande Casteele N.

Clin Transl Gastroenterol. 2017 Nov 2;8(11):e126. doi: 10.1038/ctg.2017.52.

13.

Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer.

Vincent MD, Breadner D, Cripps MC, Jonker DJ, Klimo P, Biagi JJ, Lam W, O'Connell A, Whiston F, Stitt L, Welch SA.

Curr Oncol. 2017 Aug;24(4):e261-e268. doi: 10.3747/co.24.3516. Epub 2017 Aug 31.

14.

A Prospective Randomized Study of Endoscopic Versus Conventional Harvesting of the Radial Artery.

Kiaii BB, Swinamer SA, Fox SA, Stitt L, Quantz MA, Novick RJ.

Innovations (Phila). 2017 Jul/Aug;12(4):231-238. doi: 10.1097/IMI.0000000000000386.

PMID:
28763350
15.

Reliability of EUS indices to detect inflammation in ulcerative colitis.

Yan B, Feagan B, Teriaky A, Mosli M, Mohamed R, Williams G, Yeung E, Yong E, Haig A, Sey M, Stitt L, Zou GY, Jairath V.

Gastrointest Endosc. 2017 Dec;86(6):1079-1087. doi: 10.1016/j.gie.2017.07.035. Epub 2017 Jul 29.

PMID:
28760533
16.

The development of a magnetic resonance imaging index for fistulising Crohn's disease.

Samaan MA, Puylaert CAJ, Levesque BG, Zou GY, Stitt L, Taylor SA, Shackelton LM, Vandervoort MK, Khanna R, Santillan C, Rimola J, Hindryckx P, Nio CY, Sandborn WJ, D'Haens G, Feagan BG, Jairath V, Stoker J.

Aliment Pharmacol Ther. 2017 Sep;46(5):516-528. doi: 10.1111/apt.14190. Epub 2017 Jun 27.

17.

Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.

D'Haens GR, Sandborn WJ, Zou G, Stitt LW, Rutgeerts PJ, Gilgen D, Jairath V, Hindryckx P, Shackelton LM, Vandervoort MK, Parker CE, Muller C, Pai RK, Levchenko O, Marakhouski Y, Horynski M, Mikhailova E, Kharchenko N, Pimanov S, Feagan BG.

Aliment Pharmacol Ther. 2017 Aug;46(3):292-302. doi: 10.1111/apt.14164. Epub 2017 Jun 1.

18.

Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes.

VanDenKerkhof EG, Stitt L, Clark AJ, Gordon A, Lynch M, Morley-Forster PK, Nathan HJ, Smyth C, Toth C, Ware MA, Moulin DE.

Clin J Pain. 2018 Jan;34(1):30-36. doi: 10.1097/AJP.0000000000000512.

PMID:
28481836
19.

Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.

Khanna R, Zou G, Stitt L, Feagan BG, Sandborn WJ, Rutgeerts P, McDonald JWD, Dubcenco E, Fogel R, Panaccione R, Jairath V, Nelson S, Shackelton LM, Huang B, Zhou Q, Robinson AM, Levesque BG, D'Haens G.

Am J Gastroenterol. 2017 Jun;112(6):975. doi: 10.1038/ajg.2017.120. Epub 2017 Apr 18. No abstract available.

PMID:
28417993
20.

The reciprocal associations between catastrophizing and pain outcomes in patients being treated for neuropathic pain: a cross-lagged panel analysis study.

Racine M, Moulin DE, Nielson WR, Morley-Forster PK, Lynch M, Clark AJ, Stitt L, Gordon A, Nathan H, Smyth C, Ware MA, Jensen MP.

Pain. 2016 Sep;157(9):1946-1953. doi: 10.1097/j.pain.0000000000000594.

PMID:
28146042
21.

Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.

Khanna R, Zou G, Stitt L, Feagan BG, Sandborn WJ, Rutgeerts P, McDonald JWD, Dubcenco E, Fogel R, Panaccione R, Jairath V, Nelson S, Shackelton LM, Huang B, Zhou Q, Robinson AM, Levesque BG, D'Haens G.

Am J Gastroenterol. 2017 Oct;112(10):1584-1592. doi: 10.1038/ajg.2016.580. Epub 2017 Jan 10. Erratum in: Am J Gastroenterol. 2017 Jun;112(6):975.

PMID:
28071654
22.

Long-Term Outcomes in the Management of Painful Diabetic Neuropathy.

Mai LM, Clark AJ, Gordon AS, Lynch ME, Morley-Forster PK, Nathan H, Smyth C, Stitt LW, Toth C, Ware MA, Moulin DE.

Can J Neurol Sci. 2017 Jul;44(4):337-342. doi: 10.1017/cjn.2016.429. Epub 2017 Jan 9.

PMID:
28065184
23.

Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer.

Vincent MD, Breadner D, Soulieres D, Kerr IG, Sanatani M, Kocha W, Klimo P, MacKenzie MJ, O'Connell A, Whiston F, Malpage AS, Stitt L, Welch SA.

Future Oncol. 2017 Apr;13(9):777-786. doi: 10.2217/fon-2016-0444. Epub 2017 Jan 3.

PMID:
28045335
24.

Pain expectations in neuropathic pain: Is it best to be optimistic?

Bostick GP, Kamper SJ, Haanstra TM, Dick BD, Stitt LW, Morley-Forster P, Clark AJ, Lynch ME, Gordon A, Nathan H, Smyth C, Ware MA, Toth C, Moulin DE.

Eur J Pain. 2017 Apr;21(4):605-613. doi: 10.1002/ejp.962. Epub 2016 Oct 14.

PMID:
27739623
25.

High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.

Huang K, D'Souza D, Patil N, Velker V, Leung E, Stitt L, Whiston F, Sugimoto A, McGee J, Prefontaine M.

Brachytherapy. 2016 Sep-Oct;15(5):543-8. doi: 10.1016/j.brachy.2016.06.010. Epub 2016 Jul 27.

PMID:
27475479
26.

Pretreatment Serum Folate Levels and Toxicity/Efficacy in Colorectal Cancer Patients Treated With 5-Fluorouracil and Folinic Acid.

Yan M, Ho C, Winquist E, Jonker D, Rayson D, Stitt L, Tokmakejian S, Tomiak A, Vincent MD.

Clin Colorectal Cancer. 2016 Dec;15(4):369-376.e3. doi: 10.1016/j.clcc.2016.06.001. Epub 2016 Jun 23.

PMID:
27474080
27.

Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.

Dubcenco E, Zou G, Stitt L, Baker JP, Jeejeebhoy KN, Kandel G, Kim YI, Grover SC, McDonald JW, Shackelton LM, Khanna R, D'Haens G, Sandborn WJ, Feagan BG, Levesque BG.

J Crohns Colitis. 2016 Sep;10(9):1006-14. doi: 10.1093/ecco-jcc/jjw120. Epub 2016 Jul 6.

PMID:
27385400
28.

Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.

Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, Dar AR, Lambert C, Pond G, Stitt L, Tay KY, Rodrigues G.

J Neurooncol. 2016 Jul;128(3):431-6. doi: 10.1007/s11060-016-2128-7. Epub 2016 Apr 15.

PMID:
27084705
29.

Urethral injury in laparoscopic-assisted abdominoperineal resection.

Stitt L, Flores FA, Dhalla SS.

Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E900-2. doi: 10.5489/cuaj.3259. Epub 2015 Dec 14.

30.

Usefulness of Ki-67, Mitoses, and Tumor Size for Predicting Metastasis in Carcinoid Tumors of the Lung: A Study of 48 Cases at a Tertiary Care Centre in Canada.

Joseph MG, Shibani A, Panjwani N, Arab A, Shepherd J, Stitt LW, Inculet R.

Lung Cancer Int. 2015;2015:545601. doi: 10.1155/2015/545601. Epub 2015 Dec 6.

31.

Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis.

Yu E, Stitt L, Vujovic O, Joseph K, Assouline A, Younus J, Perera F, Tai P.

Cureus. 2015 Oct 16;7(10):e355. doi: 10.7759/cureus.355.

32.

Development and validation of a histological index for UC.

Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Shackelton LM, Walker CW, Nelson S, Vandervoort MK, Frisbie V, Samaan MA, Jairath V, Driman DK, Geboes K, Valasek MA, Pai RK, Lauwers GY, Riddell R, Stitt LW, Levesque BG.

Gut. 2017 Jan;66(1):50-58. doi: 10.1136/gutjnl-2015-310393. Epub 2015 Oct 16.

PMID:
26475633
33.

Impact on health-related quality of life and costs of managing chronic neuropathic pain in academic pain centres: Results from a one-year prospective observational Canadian study.

Tarride JE, Moulin DE, Lynch M, Clark AJ, Stitt L, Gordon A, Morley-Forster PK, Nathan H, Smyth C, Toth C, Ware MA.

Pain Res Manag. 2015 Nov-Dec;20(6):327-33. Epub 2015 Oct 16.

34.

Intraurethral Lidocaine for Urethral Catheterization in Children: A Randomized Controlled Trial.

Poonai N, Li J, Langford C, Lepore N, Taddio A, Gerges S, Stitt L, Teefy J, Manji K, Castelo M, Rieder M, Qui T, Matsui D, Ali S.

Pediatrics. 2015 Oct;136(4):e879-86. doi: 10.1542/peds.2015-1852.

35.

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.

Jairath V, Khanna R, Zou GY, Stitt L, Mosli M, Vandervoort MK, D'Haens G, Sandborn WJ, Feagan BG, Levesque BG.

Aliment Pharmacol Ther. 2015 Nov;42(10):1200-10. doi: 10.1111/apt.13408. Epub 2015 Sep 21.

36.

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG; REACT Study Investigators.

Lancet. 2015 Nov 7;386(10006):1825-34. doi: 10.1016/S0140-6736(15)00068-9. Epub 2015 Sep 3.

PMID:
26342731
37.

A case-control, mono-center, open-label, pilot study to evaluate the feasibility of therapeutic touch in preventing radiation dermatitis in women with breast cancer receiving adjuvant radiation therapy.

Younus J, Lock M, Vujovic O, Yu E, Malec J, D'Souza D, Stitt L.

Complement Ther Med. 2015 Aug;23(4):612-6. doi: 10.1016/j.ctim.2014.11.003. Epub 2014 Dec 5.

PMID:
26275655
38.

(99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.

Belhocine TZ, Blankenberg FG, Kartachova MS, Stitt LW, Vanderheyden JL, Hoebers FJ, Van de Wiele C.

Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2083-97. doi: 10.1007/s00259-015-3152-0. Epub 2015 Aug 16. Review.

PMID:
26275392
39.

Role of plasma osteopontin as a biomarker in locally advanced breast cancer.

Anborgh PH, Caria LB, Chambers AF, Tuck AB, Stitt LW, Brackstone M.

Am J Transl Res. 2015 Apr 15;7(4):723-32. eCollection 2015.

40.

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease.

Khanna R, Zou G, D'Haens G, Rutgeerts P, McDonald JW, Daperno M, Feagan BG, Sandborn WJ, Dubcenco E, Stitt L, Vandervoort MK, Donner A, Luo A, Levesque BG.

Gut. 2016 Jul;65(7):1119-25. doi: 10.1136/gutjnl-2014-308973. Epub 2015 May 2.

PMID:
25935574
41.

Catheter based selective hypothermia reduces stroke volume during focal cerebral ischemia in swine.

Mattingly TK, Denning LM, Siroen KL, Lehrbass B, Lopez-Ojeda P, Stitt L, Pelz DM, Das S, Ang LC, Lee DH, Lownie SP.

J Neurointerv Surg. 2016 Apr;8(4):418-22. doi: 10.1136/neurintsurg-2014-011562. Epub 2015 Feb 12.

PMID:
25676148
42.

Physical Functioning and Opioid use in Patients with Neuropathic Pain.

Bostick GP, Toth C, Carr EC, Stitt LW, Morley-Forster P, Clark AJ, Lynch M, Gordon A, Nathan H, Smyth C, Ware MA, Moulin DE.

Pain Med. 2015 Jul;16(7):1361-8. doi: 10.1111/pme.12702. Epub 2015 Feb 3.

PMID:
25645728
43.

Time interval from breast-conserving surgery to breast irradiation in early stage node-negative breast cancer: 17-year follow-up results and patterns of recurrence.

Vujovic O, Yu E, Cherian A, Dar AR, Stitt L, Perera F.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):319-24. doi: 10.1016/j.ijrobp.2014.10.006.

PMID:
25636757
44.

Postoperative atrial fibrillation is not pulmonary vein dependent: results from a randomized trial.

Kiaii B, Fox S, Chase L, Fernandes M, Stitt LW, Guo R, Quantz M, Chu MW, Koka P, McClure RS, McKenzie FN, Klein GJ, Novick RJ, Skanes AC.

Heart Rhythm. 2015 Apr;12(4):699-705. doi: 10.1016/j.hrthm.2015.01.014. Epub 2015 Jan 13.

PMID:
25595923
45.

Clozapine response and pre-treatment EEG-is there some kind of relationship.

Shrivastava A, Johnston M, Shah N, Stitt L, Shrivastava S, Sousa AD.

Ind Psychiatry J. 2014 Jan;23(1):18-22. doi: 10.4103/0972-6748.144951.

46.

An adaptive role for negative expected pain in patients with neuropathic pain.

Bostick GP, Toth C, Dick BD, Carr EC, Stitt LW, Moulin DE.

Clin J Pain. 2015 May;31(5):438-43. doi: 10.1097/AJP.0000000000000135.

PMID:
25370145
47.

Reproducibility of histological assessments of disease activity in UC.

Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, MacDonald JK, Vandervoort MK, Samaan MA, Geboes K, Valasek MA, Pai R, Langner C, Riddell R, Harpaz N, Sewitch M, Peterson M, Stitt LW, Levesque BG.

Gut. 2015 Nov;64(11):1765-73. doi: 10.1136/gutjnl-2014-307536. Epub 2014 Oct 30.

PMID:
25360036
48.

Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial.

Poonai N, Bhullar G, Lin K, Papini A, Mainprize D, Howard J, Teefy J, Bale M, Langford C, Lim R, Stitt L, Rieder MJ, Ali S.

CMAJ. 2014 Dec 9;186(18):1358-63. doi: 10.1503/cmaj.140907. Epub 2014 Oct 27.

49.

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.

Vande Casteele N, Khanna R, Levesque BG, Stitt L, Zou GY, Singh S, Lockton S, Hauenstein S, Ohrmund L, Greenberg GR, Rutgeerts PJ, Gils A, Sandborn WJ, Vermeire S, Feagan BG.

Gut. 2015 Oct;64(10):1539-45. doi: 10.1136/gutjnl-2014-307883. Epub 2014 Oct 21.

50.

Tolerability of the combination of ginger (Zingiber officinalis), gentian (Gentiana lutea) and turmeric (Curcuma longa) in patients with cancer-associated anorexia.

Sanatani M, Younus J, Stitt L, Malik N.

J Complement Integr Med. 2015 Mar;12(1):57-60. doi: 10.1515/jcim-2013-0064.

PMID:
25324460

Supplemental Content

Support Center